Journal Impact Factor

«“√ “√
∫∑∫√√≥“∏‘°“√
‡∑§π‘§°“√·æ∑¬å·≈–°“¬¿“æ∫”∫—¥
EDITORIAL
JOURNAL OF MEDICAL TECHNOLOGY AND PHYSICAL THERAPY
Journal Impact Factor
ÿæ√√≥ øŸÉ‡®√‘≠*
¢—ÈπµÕ𠔧—≠¢—ÈπµÕπÀπ÷ËߢÕß°“√∑”ß“π«‘®—¬„¥Ê §◊Õ °“√π”º≈ß“π«‘®—¬∑’ˉ¥â ‰ªµ’æ‘¡æ出¬·æ√à „π«“√ “√«‘™“
°“√∑’ˇ°’ˬ«¢âÕß ‡æ◊ËÕ„Àâº≈ß“π«‘®—¬π—Èπ‰¥â√—∫°“√µ√«® Õ∫·≈–ª√–‡¡‘π§ÿ≥¿“殓°ºŸâ∑√ߧÿ≥«ÿ≤‘„π«ß°“√·≈–‡ªìπ°“√
‡º¬·æ√àº≈ß“π«‘®¬— ‰ª Ÿºà ∑Ÿâ ®’Ë – “¡“√∂„™âª√–‚¬™π宓°º≈ß“π«‘®¬— π—πÈ Ê ‰¥â ªí®®ÿ∫π— ®÷ß¡’«“√ “√∑“ß«‘™“°“√µà“ßÊ ‡°‘¥¢÷πÈ
¡“°¡“¬„πÀ≈“¬Ê “¢“ ∑—ßÈ „π√–¥—∫ ∂“∫—π √–¥—∫ ¡“§¡«‘™“™’æ √–¥—∫™“µ‘·≈–√–¥—∫π“π“™“µ‘ ‚¥¬∑—«Ë ‰ªÀ“° “¡“√∂
µ’æ‘¡æ出¬·æ√àº≈ß“π«‘®—¬‰¥â„π√–¥—∫π“π“™“µ‘ °Á¡—°®–∂◊Õ«à“‡ªìπº≈ß“π«‘®—¬∑’Ë¥’ ¡’§ÿ≥¿“æ·≈–ª√– ∫§«“¡ ”‡√Á®„π
°“√¥”‡π‘πß“π«‘®¬— Ÿß π—°«‘®¬— ·≈–Àπ૬ߓπ∑’ Ë ß— °—¥°Á®–‰¥â√∫— ‡§√¥‘µ∑’¥Ë ’ ‡æ√“–°“√µ’æ¡‘ æ出¬·æ√àº≈ß“π«‘®¬— „π√–¥—∫
π“π“™“µ‘ ∂◊Õ‡ªìπªí®®—¬ ”§—≠Õ¬à“ßÀπ÷Ëß∑’Ë „™â „π°“√ª√–‡¡‘π§ÿ≥¿“æπ—°«‘®—¬ Àπ૬ߓπ∑’Ë —ß°—¥ °“√„Àâ√“ß«—≈À√◊Õ
®—¥ √√∑ÿπ π—∫ πÿπ°“√«‘®—¬¢Õß·À≈àß∑ÿπµà“ßÊ·≈–‡ªìπªí®®—¬ ”§—≠∑’Ë „™â „π°“√®—¥Õ—π¥—∫§«“¡‡¢â¡·¢Áߥâ“π°“√«‘®—¬
¢ÕßÀπ૬ߓπ Õ¬à“߉√°Áµ“¡À“°æ‘®“√≥“∂÷ß®”π«π«“√ “√∑“ß«‘™“°“√„π√–¥—∫π“π“™“µ‘∑¡’Ë Õ’ ¬Ÿà„π∞“π¢âÕ¡Ÿ≈ “°≈ ‡™àπ
PubMed À√◊Õ Medline °Áπ—∫‰¥â¡“°°«à“ 10,000 ©∫—∫ ¡’§ÿ≥¿“æ¡“°πâÕ¬·µ°µà“ß°—π‰ª ®÷߇ªìπ∑’Ë¡“¢Õߧ«“¡
欓¬“¡∑’Ë®–®—¥Õ—π¥—∫·≈–ª√–‡¡‘π§ÿ≥¿“æ¢Õß«“√ “√µà“ßÊ ‚¥¬°”À𥇪ìπ§à“µ—«™’È«—¥À√◊Õ¥—™π’‡æ◊ËÕ„™â „π°“√
‡ª√’¬∫‡∑’¬∫§ÿ≥¿“æ¢Õß«“√ “√¢’Èπ
Journal Impact Factor ‡ªìπ¥—™π’ ”§—≠Õ¬à“ßÀπ÷Ëß
∑’Ëæ—≤π“¢÷Èπ‚¥¬ Dr. Eugene Garfield ·Ààß Institute
for Scientific Information (ISI) ª√–‡∑» À√—∞Õ‡¡√‘°“(1)
´÷ßË ‡ªìπ¥—™π’∑’ˉ¥â√∫— °“√¬Õ¡√—∫Õ¬à“ß°«â“ߢ«“ß §à“ Journal
Impact Factor ¢Õß ISI π’È §”π«≥®“°§«“¡∂’Ë‚¥¬
‡©≈’ˬ¢Õß∫∑§«“¡ 1 ∫∑§«“¡„π«“√ “√„¥Ê∑’Ë∂Ÿ°Õâ“ßÕ‘ß
(citation) „π™à«ß√–¬–‡«≈“ 2 ªï¬âÕπÀ≈—ߢÕߪï∑’Ë
µâÕß°“√ª√–‡¡‘π§à“ Impact Factor ¢Õß«“√ “√π—Èπ ‚¥¬
¡’À≈—°°“√æ◊Èπ∞“π∑’ˇ™◊ËÕ«à“À“°‡ªìπ«“√ “√∑’Ë¡’§ÿ≥¿“楒
∫∑§«“¡∑’µË æ’ ¡‘ æå„π«“√ “√π—πÈ °Á§«√®–‰¥â√∫— °“√Õâ“ßÕ‘ß Ÿß
ISI ‰¥â°”Àπ¥§à“ Impact Factor ‚¥¬π”®”π«π§√—Èß
¢Õß°“√∂Ÿ°Õâ“ßÕ‘ß„πªï∑’˧”π«≥§à“ Impact Factor ¢Õß
∫∑§«“¡∑’˵’æ‘¡æå„π™à«ß 2 ªï¬âÕπÀ≈—ß À“√¥â«¬®”π«π
∫∑§«“¡∑—ÈßÀ¡¥∑’˵’æ‘¡æå≈ß„π«“√ “√π—ÈπÊ„π™à«ß 2 ªï
¬âÕπÀ≈—ßπ—Èπ ´÷Ëß®–À¡“¬∂÷ß§à“‡©≈’ˬ¢Õß°“√Õâ“ßÕ‘ß
∫∑§«“¡ 1 ∫∑§«“¡„π√Õ∫ªï∑’˧”π«≥
µ—«Õ¬à“ß°“√§”π«≥§à“ Impact Factor „πªï §.».
2004 (2004 Impact Factor) ¢Õß«“√ “√ Haematologica
´÷Ë߇ªìπ«“√ “√∑“ß°“√¢Õß ¡“§¡‚≈À‘µ«‘∑¬“·Ààß∑«’ª
¬ÿ‚√ª (European Hematology Association, ESH)
¡’¢âÕ¡Ÿ≈ª√–°Õ∫°“√§”π«≥§à“ 2004 Impact Factor
¥—ßπ’È (2)
®”π«π§√—ÈߢÕß°“√Õâ“ßÕ‘ß„πªï §.». 2004 ¢Õß
∫∑§«“¡∑’˵’æ‘¡æå„πªï 2003 = 580
®”π«π§√—ÈߢÕß°“√Õâ“ßÕ‘ß„πªï §.». 2004 ¢Õß
∫∑§«“¡∑’˵’æ‘¡æå„πªï 2002 = 644
»Ÿπ¬å«‘®—¬·≈–æ—≤π“°“√µ√«®«‘π‘®©—¬∑“ßÀâÕߪؑ∫—µ‘°“√∑“ß°“√·æ∑¬å
§≥–‡∑§π‘§°“√·æ∑¬å ¡À“«‘∑¬“≈—¬¢Õπ·°àπ
* ºŸâ√—∫º‘¥™Õ∫∫∑§«“¡
* Corresponding author (e-mail: [email protected])
J Med Tech Phy Ther ë Vol.19 No.3 ë SEPTEMBER-DECEMBER 2007
189
«“√ “√
‡∑§π‘§°“√·æ∑¬å·≈–°“¬¿“æ∫”∫—¥
JOURNAL OF MEDICAL TECHNOLOGY AND PHYSICAL THERAPY
√«¡®”π«π§√—ßÈ ¢Õß°“√Õâ“ßÕ‘ß∫∑§«“¡∑’µË æ’ ¡‘ æå„πªï
2002 - 2003 = 580 + 644 = 1,224
®”π«π∫∑§«“¡∑—ßÈ À¡¥∑’µË æ’ ¡‘ æå„πªï §.». 2003
¢Õß«“√ “√ = 146 ‡√◊ËÕß
®”π«π∫∑§«“¡∑—ßÈ À¡¥∑’µË æ’ ¡‘ æå„πªï §.». 2002
¢Õß«“√ “√ = 146 ‡√◊ËÕß
√«¡®”π«π∫∑§«“¡∑’µË æ’ ¡‘ æå„πªï 2002 - 2003
= 146 + 146 = 292
§à “ 2004 Impact Factor ¢Õß«“√ “√
Haematologica ®÷ߧ”π«≥‰¥â®“° 1,224 / 292 = 4.192
§à“ Impact Factor ∑’˧”π«≥‰¥â „π·µà≈–ªï¢Õß
«“√ “√®÷߇ª≈’ˬπ·ª≈߉¥â ¢÷ÈπÕ¬Ÿà°—∫Õ—µ√“°“√Õâ“ßÕ‘ß∑’Ë
‡ª≈’¬Ë π·ª≈߉ª„π·µà≈–ªï ‡™àπ «“√ “√ Haematologica
´÷Ëß¡’§à“ Impact Factor „πªï 2004 ‡∑à“°—∫ 4.192 π’È
¡’§“à Impact Factor „πªï §.». 2005 ·≈– 2006 ‡∑à“°—∫
4.575 ·≈– 5.032 µ“¡≈”¥—∫ ª°µ‘ ISI ®–ª√–°“»§à“
Impact Factor ¢Õß«“√ “√„π√Õ∫ªï∑’˺à“π¡“„π√“«
°≈“߇¥◊Õπ¡‘∂ÿπ“¬π¢Õß∑ÿ°ªï (§à“ Impact Factor ∑’Ë„™â
Õ¬Ÿà „πªí®®ÿ∫—π §◊Õ 2006 Impact Factor ´÷Ë߉¥â√—∫°“√
ª√–°“»„π‡¥◊Õπ¡‘∂πÿ “¬π æ.». 2550) ‚¥¬∑—«Ë ‰ª«“√ “√
∑’¥Ë ¡’ §’ ≥
ÿ ¿“æ Ÿß ¡—°®–¡’§“à Impact Factor ‡ª≈’¬Ë π·ª≈ß
‰ª„π∑‘»∑“ß∑’Ë Ÿß¢÷ÈπÕ¬à“ßµàÕ‡π◊ËÕß ´÷Ëß®–À¡“¬∂÷ßæ—≤π“
°“√¥â“π§ÿ≥¿“æ·≈–§«“¡π‘¬¡¢Õß«“√ “√µ≈Õ¥®π
·π«‚πâ¡¢Õß§à“ Impact Factor „πÕ𓧵¢Õß«“√ “√
À“°æ‘®“√≥“‡ª√’¬∫‡∑’¬∫«“√ “√ 2 ©∫—∫∑’Ë¡’§à“ Impact
Factor „πªï‡¥’¬«°—π‡∑à“°—π «“√ “√∑’Ë¡’·π«‚πâ¡°“√
‡ª≈’ˬπ·ª≈ß§à“ Impact Factor ‡ªìπ‰ª„π·π«∑‘»∑“ß
∑’ Ë ßŸ ¢÷πÈ ∂◊Õ‡ªìπ«“√ “√∑’ˉ¥â√∫— §«“¡π‘¬¡¡“°°«à“(3) ‚¥¬
∑—Ë « ‰ª°Õß∫√√≥“∏‘ ° “√«“√ “√®–„Àâ § «“¡ ”§— ≠ ·≈–
欓¬“¡√—°…“ ∂‘µ‘§ÿ≥¿“æ¢Õß«“√ “√„Àâ¡’·π«‚πâ¡°“√
‡ª≈’¬Ë π·ª≈ß§à“ Impact Factor ‰ª„π∑“ß∑’ Ë ßŸ ¢÷πÈ (4) ·≈–
ª√–°“»„Àâ∑√“∫‚¥¬∑—Ë«°—π¥—ß· ¥ß„π √Ÿª∑’Ë 1 ∂◊Õ‡ªìπ
°“√ª√–™“ —¡æ—π∏å«“√ “√√Ÿª·∫∫Àπ÷Ëß °“√¥”‡π‘πß“π
¢Õß°Õß∫√√≥“∏‘°“√«“√ “√ ®÷ß欓¬“¡∑’Ë®–‡≈◊Õ°√—∫
‡©æ“–∫∑§«“¡∑’Ë¡’§ÿ≥¿“æ Ÿß·≈–‡ªìπ‡√◊ËÕß∑’Ë°”≈—߇ªìπ∑’Ë
190
∫∑∫√√≥“∏‘°“√
EDITORIAL
π„®„π«ß°«â“ß·≈–‡¢â“∂÷ߺŸÕâ “à π‰¥â¡“° ®“°«‘∏°’ “√§”π«≥
¥—ß°≈à“«®–‡ÀÁπ‰¥â«à“ «“√ “√∑’Ë¡’¬Õ¥ºŸâÕà“π¡“°·≈–Õ¬Ÿà
„πÀ≈“¬ “¢“«‘™“°“√ (General Journal) ®–¡’‚Õ°“ ‰¥â√—∫°“√Õâ“ßÕ‘ß¡“°°«à“«“√ “√∑’Ë¡’ºŸâÕà“π®”°—¥Õ¬Ÿà „π
“¢“„¥ “¢“Àπ÷Ëß (Specific Journal) µ—«Õ¬à“ß«“√ “√
™—Èππ”¥â“π°“√·æ∑¬å∑’Ë¡’§à“ 2006 Impact Factor Ÿß
·≈–®—¥‡ªìπ°≈ÿà¡«“√ “√ ”À√—∫∑ÿ° “¢“«‘™“°“√ ‰¥â·°à
N Engl J Med (51.296) Science (30.028) Cell
(29.194) Nature Med (28.588) Lancet (25.800)
·≈– Nature Genetics (24.176) ‡ªìπµâπ à«π«“√ “√
‡©æ“– “¢“ à«π„À≠à®–¡’§“à Impact Factor µË”°«à“ ‡™àπ
Blood (10.37) Clin Chem (5.454) Am J Clin Pathol
(2.939) Clin Chim Acta (2.328) Clin Diagn Lab
Immunol (1.988) ·≈– Clin Lab Haematol (0.921)
‡ªìπµâπ ‚¥¬∑—Ë«‰ª«“√ “√∑’Ë¡’§à“ Impact Factor ŸßÊ
®–‰¥â √— ∫ ∫∑§«“¡∑’Ë à ß ‰ª¢Õµ’ æ‘ ¡ æå ® “°π— ° «‘ ®— ¬ ‡ªì π
®”π«π¡“° °Õß∫√√≥“∏‘°“√®÷ß¡’‚Õ°“ ‡≈◊Õ°√—∫µ’æ‘¡æå
„À⇩擖∫∑§«“¡∑’Ë¡’§ÿ≥¿“æ Ÿß‰¥â «“√ “√‡À≈à“π’È®÷ß¡—°
¡’Õ—µ√“°“√µÕ∫√—∫∫∑§«“¡‡æ◊ËÕµ’æ‘¡æå (Acceptance
rate) µË” ·µà®–¡’Õ—µ√“°“√ªØ‘‡ ∏∫∑§«“¡ (Rejection
rate) Ÿß°«à“«“√ “√∑’Ë¡’§à“ Impact Factor µË” ¥—ßπ—Èπ
‡¡◊ËÕ àß∫∑§«“¡‰ª¢Õµ’æ‘¡æå „π«“√ “√∑’Ë¡’§à“ Impact
Factor Ÿß ®÷ß¡’‚Õ°“ ∂Ÿ°ªØ‘‡ ∏∫∑§«“¡ Ÿß°«à“ π—°«‘®¬—
∑’Ë¡’§«“¡√Ÿâ§«“¡‡¢â“„®·≈–§ÿâπ‡§¬„π‡√◊ËÕßπ’È¥’ ®–æ‘®“√≥“
‡≈◊ Õ ° à ß ∫∑§«“¡«‘ ®— ¬ ¢Õßµπ‡Õ߉ª¬— ß «“√ “√∑’Ë ¡’ §à “
Impact Factor ‡À¡“– ¡°—∫√–¥—∫º≈ß“π∑’¡Ë §’ “à Impact
Factor ‰¡à ŸßÀ√◊յ˔®π‡°‘π‰ª ´÷Ëß®–∑”„Àâ¡’‚Õ°“ ‰¥â√—∫
°“√µÕ∫√—∫ Ÿß°«à“ ¥—ßπ—Èπ §à“ Impact Factor ®÷߇ªìπ
ªí®®—¬ ”§—≠Õ¬à“ßÀπ÷Ëß„π°“√æ‘®“√≥“‡≈◊Õ°«“√ “√∑’Ë®–
à߇√◊ËÕ߉ª¢Õµ’æ‘¡æå¢Õßπ—°«‘®—¬ à«π„À≠à¥â«¬
«“√ “√‡∑§π‘§°“√·æ∑¬å·≈–°“¬¿“æ∫”∫—¥ ë ªï∑’Ë 19 ©∫—∫∑’Ë 3 ë °—𬓬π-∏—𫓧¡ 2550
√Ÿª∑’Ë 1 ·π«‚πâ¡°“√‡ª≈’ˬπ·ª≈ß§à“ Impact Factor ¢Õß«“√ “√ Haematologica „π™à«ß 15 ªï √–À«à“ߪï
§.». 1991 - 2005
Õ¬à“߉√°Áµ“¡À“°æ‘®“√≥“µ“¡®”π«π«“√ “√√–¥—∫
π“π“™“µ‘∑’Ë¡’Õ¬Ÿà¡“°°«à“ 10,000 ©∫—∫π—Èπ ¡’‡æ’¬ß
ª√–¡“≥√âÕ¬≈– 60 (°«à“ 6,000 ©∫—∫) ‡∑à“π—Èπ∑’Ë∂Ÿ°
§—¥‡≈◊Õ°·≈–Õ¬Ÿà „π‡°≥±å¢Õß ISI ∑’ˉ¥â√—∫°“√ª√–‡¡‘π
§ÿ≥¿“æ·≈–¡’§“à Impact Factor ∑’‡Ë À≈◊ÕÕ’°‡°◊Õ∫ 4,000
©∫—∫‰¡àÕ¬Ÿà„π‡°≥±å¢Õß ISI ®÷߉¡à¡’§à“ Impact Factor
·¡â®–®—¥‡ªìπ«“√ “√„π√–¥—∫π“π“™“µ‘°µÁ “¡∑—ßÈ π’‡È π◊ÕË ß®“°
ISI ‰¥â °”À𥇰≥±å ∑’Ë ‡ ¢â ¡ ß«¥∑—È ß ¥â “ π§ÿ ≥ ¿“æ·≈–
ª√‘¡“≥‰«âÀ≈“¬ª√–°“√„π°“√æ‘®“√≥“§—¥‡≈◊Õ°«“√ “√
·≈–„™â‡«≈“„π°“√æ‘®“√≥“«“√ “√Õ¬à“ßµàÕ‡π◊ËÕß√–¬–
‡«≈“Àπ÷Ëß®÷ß®–„Àâ°“√√—∫√Õß „π·µà≈–ªï ISI ‰¥â√—∫
«“√ “√‡¢â“ Ÿà°√–∫«π°“√µ√«®ª√–‡¡‘π¡“°°«à“ 2,000
©∫—∫ ·µà¡’‡æ’¬ß√âÕ¬≈– 10 - 12 ‡∑à“π—Èπ∑’ˉ¥â√—∫°“√§—¥
‡≈◊Õ°(5) ”À√—∫«“√ “√√–¥—∫π“π“™“µ‘∑’Ë¡’∞“π°“√º≈‘µ
Õ¬Ÿà „πª√–‡∑»‰∑¬·≈–Õ¬Ÿà „π∞“π¢âÕ¡Ÿ≈ “°≈¡’Õ¬Ÿà ‰ ¡à
¡“°π—° ‡™àπ «“√ “√ ScienceAsia, J Med Ass Thai
(®æ ∑), Southeast Asian J Trop Med Public Health
·≈– Asian Pacific J Allergy & Immunology ∑—ßÈ À¡¥
Õ¬Ÿà „π∞“π¢âÕ¡Ÿ≈ “°≈ ·µà¡’‡æ’¬ß«“√ “√ Asian Pacific
J Allergy & Immunology ‡∑à“π—Èπ∑’ˉ¥â√—∫°“√§—¥‡≈◊Õ°
„ÀâÕ¬Ÿà „π∞“π¢âÕ¡Ÿ≈¢Õß ISI ·≈–¡’§à“ 2006 Impact
Factor ‡∑à“°—∫ 0.455 ´÷Ëß∂◊Õ«à“ Ÿß ”À√—∫«“√ “√∑’Ë¡’∞“π
°“√º≈‘µ„πª√–‡∑» ·µà§àÕπ¢â“ߵ˔‡¡◊ËÕ‡∑’¬∫°—∫«“√ “√
π“π“™“µ‘ © ∫— ∫ Õ◊Ë π ∑’Ë Õ ¬Ÿà „ π°≈ÿà ¡ “¢“«‘ ™ “‡¥’ ¬ «°— π
(J Allergy Clin Immunnol 8.829, J Immunol 6.293,
Allergy 5.334, Immunology 3.674) à«π«“√ “√
ScienceAsia, J Med Ass Thai (®æ ∑) ·≈– Southeast
Asian J Trop Med Public Health ¬—߉¡à‰¥â√—∫°“√
§—¥‡≈◊Õ°®“° ISI ·≈–‰¡à¡’§à“ Impact Factor ∑—ÈßÊ ∑’Ë
«“√ “√‡À≈à“π’È≈â«π‡ªìπ«“√ “√‡°à“·°à∑’ˉ¥â√—∫°“√¬Õ¡√—∫
Õ¬à“ß°«â“ߢ«“ß„πª√–‡∑»·≈–‰¥â√—∫°“√®—¥æ‘¡æå¡“·≈â«
À≈“¬ ‘∫ªï °“√æ—≤π“«“√ “√√–¥—∫π“π“™“µ‘ „πª√–‡∑»
‰∑¬ „Àâ ‰¥â√—∫°“√¬Õ¡√—∫„π√–¥—∫ “°≈¡“°°«à“∑’ˇªìπÕ¬Ÿà
§ßµâÕß„™â‡«≈“„π°“√æ—≤π“Õ’°π“π ‡æ√“–µ√“∫„¥∑’Ë
J Med Tech Phy Ther ë Vol.19 No.3 ë SEPTEMBER-DECEMBER 2007
191
π—°«‘®—¬™—Èππ” à«π„À≠à¢Õߪ√–‡∑»¬—ßµâÕß°“√ àߺ≈ß“π
«‘®—¬∑’Ë¥’·≈–¡’§ÿ≥¿“æ¢Õßµπ‡Õ߉ªµ’æ‘¡æå„π«“√ “√Õ◊Ëπ
„πµà“ߪ√–‡∑»∑’Ë¡’§à“ Impact Factor Ÿß°«à“ ‚Õ°“ ∑’Ë
®–æ—≤π“«“√ “√π“π“™“µ‘ „πª√–‡∑»§ß®–‡ªìπ‰ª¥â«¬
§«“¡¬“°≈”∫“°
”À√—∫«“√ “√„πª√–‡∑»‰∑¬∑’Ë ‰¡à „™à«“√ “√√–¥—∫
π“π“™“µ‘·≈– à«π„À≠൒摡æ凪ìπ¿“…“‰∑¬´÷Ëß¡’Õ¬Ÿà‡ªìπ
®”π«π¡“°·≈–‰¡à¡§’ “à ISI Impact Factor π—πÈ ”π—°ß“π
°Õß∑ÿπ π—∫ πÿπ°“√«‘®—¬ ( °«.) ‰¥â¡’¥”√‘·≈–„Àâ∑ÿπ
π—∫ πÿπ°“√®—¥µ—ßÈ »Ÿπ¬å¥™— π’°“√Õâ“ßÕ‘ß«“√ “√‰∑¬ (Thai
Journal Citation Centre) ¢÷Èπ ‡æ◊ËÕ¥”‡π‘π°“√®—¥∑”§à“
Impact Factor ¢Õß«“√ “√‰∑¬ ‚¥¬Õ“»—¬À≈—°°“√
·≈–«‘∏°’ “√·∫∫‡¥’¬«°—∫ ISI ·µà‡√’¬°™◊ÕË «à“ TCI Impact
Factor ´÷Ëß„πªï≈à“ ÿ¥∑’˪√–°“»§à“ TCI Impact Factor
(æ.». 2549)(6) ¡’«“√ “√„πª√–‡∑»∑’ËÕ¬Ÿà „π¢à“¬°“√
æ‘®“√≥“ª√–¡“≥ 160 ©∫—∫ à«π„À≠ࡧ’ “à TCI Impact
Factor µË” ‚¥¬¡’§“à Ÿß ÿ¥‡æ’¬ß 0.286 («“√ “√欓∫“≈)
·≈–¡’¡“°°«à“§√÷Ëß∑’Ë¡’§à“ TCI Impact Factor ‡ªìπ 0
”À√—∫ «“√ “√‡∑§π‘§°“√·æ∑¬å·≈–°“¬¿“æ∫”∫—¥
‰¥â√—∫°“√®—¥‰«â „π≈”¥—∫∑’Ë 39 ·≈–¡’§à“ TCI Impact
Factor ‡∑à“°—∫ 0.043 ´÷ßË ·¡â®–®—¥«à“¡’§“à µË”¡“° ·µà°‡Á ªìπ
«“√ “√„π°≈ÿ¡à “¢“‡∑§π‘§°“√·æ∑¬å·≈–°“¬¿“æ∫”∫—¥
∑’¡Ë §’ “à TCI Impact Factor Ÿß ÿ¥ («“√ “√°“¬¿“æ∫”∫—¥
0.038, «“√ “√ À‡«™»“ µ√å 0, ®æ ∑ 0.075, Asian
Pacific J Allergy & Immunology 0.035, Southeast
Asian J Trop Med Public Health 0.049, ScienceAsia
0.058 à«π«“√ “√‡∑§π‘§°“√·æ∑¬å¢Õß ¡“§¡‡∑§π‘§
°“√·æ∑¬å·Ààߪ√–‡∑»‰∑¬ ‰¡àÕ¬Ÿà„π 160 ©∫—∫∑’ˉ¥â√—∫
°“√ª√–‡¡‘π) ¢âÕ¡Ÿ≈ TCI Impact Factor π’È · ¥ß„Àâ
‡ÀÁπ‡™àπ°—π«à“§ß®–µâÕß„™â‡«≈“Õ’°π“πæÕ ¡§«√„π°“√
æ—≤π“«“√ “√‰∑¬ ´÷ËßµâÕ߉¥â√—∫°“√§«“¡√à«¡¡◊Õ®“°∑ÿ°
ΩÉ“¬∑—Èß°Õß∫√√≥“∏‘°“√ ºŸâ∑√ߧÿ≥«ÿ≤‘ π—°«‘®—¬ºŸâ‡¢’¬π
∫∑§«“¡ ºŸÕâ “à π∫∑§«“¡µ≈Õ¥®π ¡“™‘°«“√ “√∑ÿ°∑à“π
192
‡Õ° “√Õâ“ßÕ‘ß
1. Garfield E. The Impact Factor. Current
Contents 1994; June 20. (http://www.isinet.
com/essays/journalcitationreports/7.html/).
2. The Editors. Editorials and Prospectives: 2004
Impact Factor and beyond. Haematologica
2005; 90: 1015.
3. Lopez-Abente G, Munoz-Tinoco C. Time
trends in the impact factor of public health
journals. BMC Public Health 2005; 5: 24.
4. Ellwood D. Editorial: maintaining our impact.
Aust NZ J Obstet Gynaecol 2007; 47: 351.
5. Garfield E. How ISI selects journals for
coverage†: quantitative and qualitative
considerations, Current Contents 1990†; May
28 and updated in January 2004. (http://
www.isinet.com/essays/selectionofmaterialforcoverage/199701.html/).
6. »Ÿπ¬å¥™— π’°“√Õâ“ßÕ‘ß«“√ “√‰∑¬ (http://tci.trf.or.th)
«“√ “√‡∑§π‘§°“√·æ∑¬å·≈–°“¬¿“æ∫”∫—¥ ë ªï∑’Ë 19 ©∫—∫∑’Ë 3 ë °—𬓬π-∏—𫓧¡ 2550